IDO2 and neoplasm: A unique feature of the IDO2 gene in humans is the high prevalence of two inactivating SNPs, which allow the opportunity to carry out loss-of-function studies directly in humans and to compare patients’ data with those from Ido2−/− and Ido2+/+ tumor-bearing mice.